CRL · 10-Q · 2026Q2 · Full report

Operating Expense Trends

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 72 · Surprise 74 · No source text

Six-month unallocated corporate costs increased $62.2 million, or 49.9%, to $187.0 million, raising corporate costs to 9.3% of revenue from 6.2%. The increase primarily reflected higher acquisition, integration, and divestiture costs and professional services fees for enterprise-wide efficiency initiatives. RMS six-month SG&A decreased $24.5 million, or 46.6%, to $28.1 million, while DSA SG&A decreased $17.9 million, or 14.3%, to $107.6 million. Manufacturing second-quarter SG&A increased $3.5 million, or 10.7%, to $35.9 million, primarily while revenue declined 6.3%.

Key facts

• Unallocated corporate costs for the three months ended June 27, 2026: $106,394 thousand, an increase of $35,900 thousand or 50.9% compared to $70,494 thousand in the prior-year period. source
• Increase in unallocated corporate costs of $35.9 million for the three months ended June 27, 2026 was primarily due to higher acquisition, integration and divestiture costs and higher professional services fees related to enterprise-wide efficiency initiatives. source

Impact estimates